Pharmacological inhibition of PGK1 suppresses EGFR-positive esophageal squamous cell carcinoma by dual targeting of glycolysis and autophagy-dependent EGFR degradation
Cellular Oncology · 29.04.2026 · 49 (3)
DOI: 10.1007/s13402-026-01215-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 29.04.2026. Verfasst von Juan Ge und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, 230031, P. R. China. Hauptthemen laut MEDLINE: Phosphoglycerate Kinase, Glycolysis, Autophagy, Esophageal Squamous Cell Carcinoma. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Major Science and Technology Project of Anhui Province, the Key Research and Development Program of Anhui Province, the Youth Innovation Promotion Association of CAS support.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, 230031, P. R. China.
- University of Science and Technology of China, Hefei, Anhui, 230026, P. R. China.
- Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, Anhui, 230031, P. R. China.
- Precision Cancer Medicine Engineering Research Center of Anhui Province, Hefei, Anhui, 230088, P. R. China.
- Primary Cell Engineering Joint Laboratory of Anhui Province, Hefei, Anhui, 230088, P. R. China.
- Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, 230031, P. R. China. wuhong@hmfl.ac.cn.
Förderung
- the Major Science and Technology Project of Anhui Province
- the Key Research and Development Program of Anhui Province
- the Youth Innovation Promotion Association of CAS support
- he National Natural Science Foundation of China
- the CASHIPS Director's Fund
- the CASHIPS Director’s Fund
Zitieren
APA
Ge, J., Chen, Y., Jiang, Z., Qi, S., Hu, J., Wang, B., Wang, A., Liu, Q., Wu, H., Wang, W., & Liu, J. (2026). Pharmacological inhibition of PGK1 suppresses EGFR-positive esophageal squamous cell carcinoma by dual targeting of glycolysis and autophagy-dependent EGFR degradation. Cellular Oncology, 49(3). https://doi.org/10.1007/s13402-026-01215-4
Vancouver
Ge J, Chen Y, Jiang Z, Qi S, Hu J, Wang B, et al. Pharmacological inhibition of PGK1 suppresses EGFR-positive esophageal squamous cell carcinoma by dual targeting of glycolysis and autophagy-dependent EGFR degradation. Cellular Oncology. 2026;49(3). doi:10.1007/s13402-026-01215-4
BibTeX
@article{Ge2026,
author = {Ge, Juan and Chen, Yongfei and Jiang, Zongru and Qi, Shuang and Hu, Jie and Wang, Beilei and Wang, Aoli and Liu, Qingsong and Wu, Hong and Wang, Wenchao and Liu, Jing},
title = {Pharmacological inhibition of PGK1 suppresses EGFR-positive esophageal squamous cell carcinoma by dual targeting of glycolysis and autophagy-dependent EGFR degradation},
journal = {Cellular Oncology},
year = {2026},
volume = {49},
number = {3},
doi = {10.1007/s13402-026-01215-4}
}
EUVIMED